Business Context and Reporting Period
Saratoga Investment Corp. (SAR) filed a Form 8-K on June 23, 2020, reporting events occurring on June 17, 2020. The Company is a Maryland corporation with principal executive offices in New York, New York. Its common stock and 6.25% Notes due 2025 trade on the New York Stock Exchange under the symbols "SAR" and "SAF," respectively.
Key Financial Metrics and Transaction Details
This filing details a specific debt financing transaction rather than periodic financial performance metrics such as revenue or operating cash flow.
- Debt Issuance: The Company entered into an underwriting agreement to issue $37,500,000 aggregate principal amount of 7.25% Notes due 2025.
- Over-Allotment Option: Underwriters have the option to purchase up to an additional $5,625,000 of Notes within 30 days of the final prospectus supplement date.
- Listing Details: The new Notes are intended to be listed on the New York Stock Exchange under the trading symbol "SAC."
- Underwriter: Ladenburg Thalmann & Co. Inc. served as the representative of the underwriters.
Material Changes Versus Prior Period
The filing does not provide comparative financial data or discuss changes in revenue, profit, or margins versus prior periods. The material change reported is the creation of a new direct financial obligation through the issuance of the 7.25% Notes due 2025.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future outlook, or specific risk factors beyond the standard legal provisions of the Underwriting Agreement. The agreement includes customary representations, warranties, covenants, and indemnification provisions for the Company, the Adviser (Saratoga Investment Advisors, LLC), and the underwriters.
Key Facts for Investor Verification
- Verify the final listing status and trading symbol "SAC" for the new 7.25% Notes due 2025 on the NYSE.
- Confirm whether the underwriters exercised the option to purchase the additional $5,625,000 of Notes within the 30-day window.
- Review the full text of the Underwriting Agreement (Exhibit 10.1) for specific covenants and use of proceeds.
- Check subsequent filings for the impact of this new debt on the Company's leverage ratios and liquidity position.